GO:0016126 sterol biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016126 sterol biosynthetic process describes the chemical reactions and pathways that produce sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain.
• Sterol biosynthesis is a multi-step, oxygen-dependent pathway that converts acetyl-CoA into cholesterol in mammals and into ergosterol or phytosterols in fungi and plants.
• Key regulatory nodes include HMG-CoA reductase (HMGCR), which is controlled by post-translational degradation and sterol-responsive feedback.
• Defects in sterol biosynthesis cause developmental, metabolic, and neurodegenerative disorders, and the pathway is a validated drug target for antifungal and cholesterol-lowering therapies.
• Sterols are not uniformly distributed in cells; they form gradients between the plasma membrane and internal organelles, influencing signaling and membrane traffic.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of sterol biosynthetic genes in human cells and animal models.
Description
Sterols are essential lipids that modulate membrane fluidity, permeability, and the activity of membrane proteins. The sterol biosynthetic process (GO:0016126) encompasses the enzymatic steps that convert simple precursors such as acetyl-CoA into sterols, including cholesterol in mammals, ergosterol in fungi, and stigmasterol or sitosterol in plants. This pathway is not merely a metabolic housekeeping route; it is tightly regulated and its intermediates serve as signaling molecules and substrates for further modifications. Researchers study sterol biosynthesis to understand membrane biology, lipid homeostasis, and the pathogenesis of disorders ranging from cardiovascular disease to neurodegeneration. The pathway is also a rich source of drug targets, as exemplified by statins that inhibit HMG-CoA reductase and azoles that block ergosterol synthesis. Because sterol biosynthetic enzymes are conserved across eukaryotes, model organisms and human cell lines provide complementary systems to dissect gene function and regulation.
sterol biosynthetic process At A Glance
| GO ID | GO:0016126 |
|---|---|
| GO term | sterol biosynthetic process |
| Ontology | biological_process |
| Synonym | sterol anabolism; sterol biosynthesis; sterol formation; sterol synthesis |
| Major function | Production of sterols such as cholesterol, ergosterol, and phytosterols from acetyl-CoA |
| Key enzymes | HMGCR, SQLE, LSS, CYP51A1, DHCR7, DHCR24, and sterol-C4 methyl oxidase complex components |
| Subcellular location | Endoplasmic reticulum and lipid droplets, with transport to plasma membrane |
| Regulation | Sterol-responsive feedback on HMGCR stability and transcription of sterol genes |
| Disease relevance | Developmental disorders, cardiovascular disease, fungal infections, and neurodegeneration |
What Is GO:0016126?
According to the Gene Ontology, GO:0016126 sterol biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of sterols, which are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule. This process includes the sequential enzymatic conversion of acetyl-CoA through the mevalonate pathway, squalene epoxidation, cyclization to lanosterol, and the post-squalene modifications that yield the final sterol product. The term is a biological process and is distinct from sterol metabolic process, which includes both synthesis and degradation.
Why Is sterol biosynthetic process Important in Cell Biology?
Sterol biosynthesis is fundamental to eukaryotic life because sterols are indispensable membrane components and precursors of steroid hormones, bile acids, and vitamin D. The pathway is also a major therapeutic target: statins reduce cholesterol synthesis by inhibiting HMGCR, while antifungal azoles block ergosterol biosynthesis. Moreover, inherited defects in sterol biosynthetic enzymes cause severe developmental and neurological phenotypes, and altered sterol metabolism is increasingly linked to cancer and immune dysfunction. Understanding GO:0016126 therefore has broad implications for cell biology, pharmacology, and precision medicine.
• Sterols maintain membrane fluidity, permeability, and lipid raft organization.
• Cholesterol is a precursor for steroid hormones, bile acids, and vitamin D.
• HMGCR is the rate-limiting enzyme and target of statin drugs.
• Ergosterol biosynthesis is the target of azole antifungals.
• Defects in post-squalene enzymes cause malformation syndromes and intellectual disability.
• Sterol intermediates such as dimethyl sterols can regulate their own pathway.
• Sterol gradients between organelles influence signaling and membrane trafficking.
• The pathway is conserved from yeast to humans, enabling model organism studies.
• 4-methyl sterols have diverse biological activities and are studied as signaling molecules.
• CRISPR screens can identify new regulators of sterol homeostasis.
What Happens During sterol biosynthetic process?
Mevalonate pathway and HMG-CoA reductase
In simple terms: The cell first makes a small building block called mevalonate, which is the committed step for making sterols.
The sterol biosynthetic process begins with the conversion of acetyl-CoA to mevalonate via HMG-CoA reductase (HMGCR), the rate-limiting enzyme. HMGCR activity is controlled by sterol-induced ubiquitination and degradation, ensuring feedback inhibition when sterols are abundant. This step is the target of statins, which lower cholesterol synthesis and are used to treat cardiovascular disease.
Squalene synthesis and cyclization to lanosterol
In simple terms: Several enzymes join mevalonate units into squalene, which is then folded into the first sterol ring structure called lanosterol.
After mevalonate, a series of enzymes including squalene synthase and squalene epoxidase convert farnesyl pyrophosphate into squalene and then 2,3-oxidosqualene. Lanosterol synthase cyclizes 2,3-oxidosqualene into lanosterol, the first sterol in the pathway. This step requires oxygen and is inhibited by chemical probes such as terbinafine, which blocks squalene epoxidase.
Post-squalene modifications and sterol-C4 oxidation
In simple terms: Lanosterol is remodeled by removing methyl groups and adding double bonds to produce the final sterol, such as cholesterol.
Post-squalene enzymes including CYP51A1, TM7SF2, LBR, SC5D, DHCR7, and DHCR24 catalyze demethylation, desaturation, and reduction reactions that convert lanosterol to cholesterol. The sterol-C4 methyl oxidase complex, which includes CYB5A and CYB5B, is required for oxidative removal of C4 methyl groups; defects in these proteins impair sterol-C4 oxidation and cause accumulation of dimethyl sterols. These intermediates can have regulatory roles, demonstrating that the pathway is not a simple linear conversion.
Sterol transport and distribution
In simple terms: Once made, sterols are moved between organelles and to the cell surface, creating distinct pools.
Sterols are not uniformly distributed; they form gradients between the endoplasmic reticulum, plasma membrane, and other organelles. Intracellular sterol dynamics involve both vesicular and non-vesicular transport, including ABC transporters and lipid transfer proteins. Maintaining these gradients is essential for membrane function and signaling, and disruption of transport can affect sterol biosynthesis feedback.
Regulation by sterol intermediates and post-translational control
In simple terms: The pathway can sense its own products and adjust enzyme levels to avoid making too much or too little sterol.
Sterol intermediates such as dimethyl sterols can regulate the pathway, as shown by defects in CYB5A and CYB5B that alter sterol-C4 oxidation and impact cholesterol biosynthesis. HMGCR is post-translationally regulated by Insig proteins and ubiquitin ligases in response to sterol levels. This feedback ensures that sterol production matches cellular demand and prevents toxic accumulation of intermediates.
Key Genes Involved in GO:0016126 sterol biosynthetic process
The following genes encode enzymes and regulators that carry out or control the sterol biosynthetic process (GO:0016126).
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGCR | Rate-limiting enzyme converting HMG-CoA to mevalonate | Target of statins; regulated by sterol-induced degradation |
| SQLE | Squalene epoxidase; converts squalene to 2,3-oxidosqualene | Target of antifungal terbinafine; oxygen-dependent step |
| LSS | Lanosterol synthase; cyclizes 2,3-oxidosqualene to lanosterol | First sterol-specific step; mutations cause cataracts and alopecia |
| CYP51A1 | Lanosterol 14-alpha demethylase | Target of azole antifungals; essential for cholesterol synthesis |
| TM7SF2 | Sterol delta-14 reductase | Post-squalene enzyme; defects cause developmental disorders |
| LBR | Lamin B receptor; sterol delta-14 reductase | Bifunctional enzyme; mutations cause Greenberg dysplasia |
| SC5D | Sterol-C5-desaturase | Converts lathosterol to 7-dehydrocholesterol; defects cause lathosterolosis |
| DHCR7 | 7-dehydrocholesterol reductase | Final step of cholesterol synthesis; defects cause Smith-Lemli-Opitz syndrome |
| DHCR24 | 24-dehydrocholesterol reductase | Converts desmosterol to cholesterol; defects cause desmosterolosis |
| CYB5A | Cytochrome b5; supports sterol-C4 oxidation | Defects impair C4 oxidation and cause dimethyl sterol accumulation |
| CYB5B | Cytochrome b5; supports sterol-C4 oxidation | Defects impair C4 oxidation and cause dimethyl sterol accumulation |
| NSDHL | Sterol-4-alpha-carboxylate 3-dehydrogenase | Part of C4 methyl oxidase complex; defects cause CHILD syndrome |
| SC4MOL | Sterol-C4-methyl oxidase | Part of C4 methyl oxidase complex; defects cause desmosterolosis-like phenotype |
| EBP | Emopamil binding protein; sterol delta-8 isomerase | Defects cause Conradi-Hunermann-Happle syndrome |
| INSIG1 | Sterol-sensing protein retaining HMGCR in ER | Regulates HMGCR degradation in response to sterols |
| INSIG2 | Sterol-sensing protein retaining HMGCR in ER | Regulates HMGCR degradation in response to sterols |
| ABCG1 | ABC transporter involved in sterol efflux | Sterol transport and gradient maintenance |
| NPC1 | Intracellular cholesterol trafficking | Sterol transport; mutations cause Niemann-Pick type C |
How Is sterol biosynthetic process Regulated?
Sterol biosynthesis is regulated at multiple levels. The rate-limiting enzyme HMGCR is controlled by sterol-responsive post-translational degradation involving Insig proteins and ubiquitin ligases. Sterol intermediates, such as dimethyl sterols, can also modulate the pathway, as shown by defects in CYB5A and CYB5B that alter sterol-C4 oxidation and affect cholesterol biosynthesis. Additionally, sterol gradients and transport between organelles influence feedback signaling, ensuring that sterol production matches cellular demand.
sterol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DHCR7 | Smith-Lemli-Opitz syndrome | Knockout or point-mutation human cell lines; cholesterol supplementation |
| DHCR24 | Desmosterolosis | Knockout mice or human iPSC-derived neurons |
| SC5D | Lathosterolosis | CRISPR knockout in HepG2 or fibroblasts |
| NSDHL | CHILD syndrome | Conditional knockout in mouse epidermis |
| CYB5A/CYB5B | Impaired sterol-C4 oxidation; dimethyl sterol accumulation | Double knockout human cells; lipidomics |
Developmental and metabolic disorders
Inherited defects in post-squalene sterol biosynthetic enzymes cause a spectrum of developmental disorders, including Smith-Lemli-Opitz syndrome (DHCR7), desmosterolosis (DHCR24), lathosterolosis (SC5D), and CHILD syndrome (NSDHL). These conditions highlight the importance of sterol biosynthesis for embryonic development and organ function. Defects in CYB5A and CYB5B impair sterol-C4 oxidation and lead to accumulation of dimethyl sterols, demonstrating that intermediate metabolites can have regulatory and pathological roles.
Cardiovascular disease and lipid disorders
HMGCR is the target of statins, which lower cholesterol biosynthesis and reduce cardiovascular risk. Dysregulation of sterol biosynthesis contributes to hypercholesterolemia and atherosclerosis, and sterol transport pathways influence lipoprotein metabolism. Studying GO:0016126 helps identify new therapeutic targets for lipid disorders.
Infectious disease and antifungal targeting
Fungal pathogens require ergosterol biosynthesis for membrane integrity, making this pathway an attractive antifungal target. Chemical inhibition of sterol biosynthesis, such as with azoles or terbinafine, disrupts fungal growth and is used clinically. Understanding the enzymatic steps in GO:0016126 can guide the development of new antifungal agents.
Neurodegeneration and sterol intermediates
Sterol intermediates and altered sterol metabolism have been linked to neurodegenerative processes, although the mechanisms are still being defined. 4-methyl sterols and other intermediates have biological activities that may affect neuronal function. Research on sterol biosynthesis in model organisms such as bees provides insights into sterol requirements in different physiological contexts.
From sterol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene essential for sterol biosynthesis? | CRISPR knockout in human cell lines (e.g., HAP1, HEK293T) |
| Does a specific point mutation affect enzyme activity? | CRISPR point-mutation knock-in in isogenic cell lines |
| Can a disease-associated variant be corrected? | CRISPR knock-in of wild-type allele or base editing |
| Where is the enzyme localized? | Endogenous tagged knock-in (e.g., GFP) |
| Does overexpression alter sterol levels? | Doxycycline-inducible overexpression in mammalian cells |
| Which genes regulate sterol homeostasis? | Genome-wide CRISPR library screening with sterol-responsive reporters |
How to Study the sterol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS lipidomics | Sterol species and intermediates | Quantify cholesterol and dimethyl sterols in knockout cells |
| RNA-seq | Transcript levels of sterol genes | Assess feedback regulation after statin treatment |
| Proteomics | Protein abundance and modifications | Monitor HMGCR degradation |
| Filipin staining | Free cholesterol distribution | Visualize sterol gradients in cells |
| CRISPR knockout screen | Gene essentiality for sterol synthesis | Identify new regulators of sterol biosynthesis |
| CRISPR activation screen | Overexpression effects on sterol levels | Discover genes that increase sterol production |
| Isotope tracing | Metabolic flux through the pathway | Measure de novo sterol synthesis |
| Immunofluorescence | Subcellular localization of enzymes | Determine ER vs. lipid droplet localization |
Lipidomics and sterol profiling
Mass spectrometry-based lipidomics quantifies sterol species such as cholesterol, lanosterol, and dimethyl sterols, allowing researchers to assess pathway flux and intermediate accumulation. This method is essential for validating genetic models of sterol biosynthesis.
Transcriptomics and proteomics
RNA-seq and quantitative proteomics measure expression of sterol biosynthetic genes and proteins, revealing transcriptional and post-translational regulation. These approaches can identify feedback responses to sterol depletion or overload.
Imaging and subcellular localization
Fluorescence microscopy with sterol-binding dyes (e.g., filipin) or tagged enzymes visualizes sterol distribution and organelle dynamics. Live-cell imaging can track sterol transport between compartments.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens coupled with sterol-responsive reporters identify novel regulators of GO:0016126. These screens can uncover genes that modulate HMGCR stability or sterol transport.
How CRISPR Can Be Used to Study GO:0016126 sterol biosynthetic process
Knockout
CRISPR knockout of sterol biosynthetic genes such as DHCR7, SC5D, or CYB5A in human cell lines abolishes enzyme activity and causes accumulation of upstream intermediates, which can be quantified by lipidomics. Knockout models are used to test whether a gene is essential for sterol production and to study compensatory pathways.
Point Mutation
CRISPR point-mutation knock-in introduces disease-associated missense variants into endogenous loci, allowing researchers to assess their impact on enzyme function and sterol flux without confounding effects of overexpression. This approach is valuable for validating variants identified in patients with sterol biosynthesis disorders.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous sterol biosynthetic genes enables real-time tracking of enzyme localization and dynamics. Knock-in of wild-type alleles can also rescue knockout phenotypes, providing causal evidence for gene function.
Overexpression
CRISPR activation or inducible overexpression of rate-limiting enzymes such as HMGCR increases sterol synthesis and can be used to study feedback regulation and lipid droplet formation. Overexpression models help identify downstream effects of increased sterol flux.
How EDITGENE Supports sterol biosynthetic process Research
Researchers studying sterol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in sterol production, how specific mutations affect enzyme activity, and where the protein acts within the cell. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for sterol biosynthetic process research.
Frequently Asked Questions About sterol biosynthetic process
What is GO:0016126 sterol biosynthetic process?
GO:0016126 is a Gene Ontology biological process term defined as the chemical reactions and pathways resulting in the formation of sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain.
What genes are involved in sterol biosynthetic process?
Key genes include HMGCR, SQLE, LSS, CYP51A1, TM7SF2, LBR, SC5D, DHCR7, DHCR24, CYB5A, CYB5B, NSDHL, SC4MOL, EBP, INSIG1, INSIG2, ABCG1, and NPC1.
What is the rate-limiting enzyme in sterol biosynthesis?
HMG-CoA reductase (HMGCR) catalyzes the committed step and is the target of statins.
How is sterol biosynthesis regulated?
It is regulated by sterol-responsive post-translational degradation of HMGCR and by feedback from sterol intermediates such as dimethyl sterols.
What diseases are linked to defects in sterol biosynthesis?
Defects cause Smith-Lemli-Opitz syndrome, desmosterolosis, lathosterolosis, CHILD syndrome, and other developmental disorders.
What is the difference between sterol biosynthesis and cholesterol biosynthesis?
Sterol biosynthesis is a broader term that includes production of cholesterol, ergosterol, and phytosterols, while cholesterol biosynthesis specifically refers to the mammalian pathway.
How can I study sterol biosynthetic process in the lab?
Common methods include lipidomics, RNA-seq, proteomics, imaging with filipin, and CRISPR screens.
What model systems are used for sterol biosynthesis research?
Human cell lines, yeast, mice, and other organisms such as bees are used to study conserved and specialized aspects of the pathway.
Why is sterol biosynthesis important for membrane function?
Sterols modulate membrane fluidity, permeability, and lipid raft organization, and they form gradients between organelles.
Can CRISPR be used to study sterol biosynthesis?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models enable causal dissection of sterol biosynthetic genes.
Conclusion
GO:0016126 sterol biosynthetic process is a central metabolic pathway that produces essential sterols in eukaryotes. Its multi-step enzymatic cascade, tight regulation, and links to human disease make it a rich area for research. CRISPR-based models and advanced analytical methods continue to reveal new insights into this pathway, offering opportunities for therapeutic intervention.
References
- 1. Peeples ES et al.. 2024. Chemical Inhibition of Sterol Biosynthesis.. Biomolecules 14(4) PMID: 38672427
- 2. Plummer AM et al.. 2021. The ABCs of Sterol Transport.. Annu Rev Physiol 83:153-181 PMID: 33141631
- 3. Menon AK. 2018. Sterol gradients in cells.. Curr Opin Cell Biol 53:37-43 PMID: 29783105
- 4. Mesmin B et al.. 2009. Intracellular sterol dynamics.. Biochim Biophys Acta 1791(7):636-45 PMID: 19286471
- 5. Ma MY et al.. 2024. Defects in CYB5A and CYB5B impact sterol-C4 oxidation in cholesterol biosynthesis and demonstrate regulatory roles of dimethyl sterols.. Cell Rep 43(11):114912 PMID: 39489939
- 6. Jo Y et al.. 2022. Post-Translational Regulation of HMG CoA Reductase.. Cold Spring Harb Perspect Biol 14(12) PMID: 35940903
- 7. Furse S et al.. 2023. Sterol and lipid metabolism in bees.. Metabolomics 19(9):78 PMID: 37644282
- 8. Darnet S et al.. 2019. Metabolism and Biological Activities of 4-Methyl-Sterols.. Molecules 24(3) PMID: 30691248
